Genetic Aspects of Atopy and Atopic Dermatitis by Agnieszka Osmola et al.
Genetic Aspects of Atopy and Atopic Dermatitis
Agnieszka Osmola, Magdalena Czarnecka-Operacz, Wojciech Silny
Allergic Diseases Diagnostic Center, Department of Dermatology, University of Medical 
Sciences, Poznań, Poland
Corresponding author:
Assist. Prof. Magdalena Czarnecka-Operacz, 
MD, PhD
Department of Dermatology





Received: July 14, 2004.
Accepted: December 20, 2004.
SUMMARY This review presents updated evidence on the ge-
netic basis of atopy and atopic dermatitis. The etiology of atopic 
processes remains partially unknown but is likely to result from 
multifactorial inheritance, with an interaction between genetic 
and environmental factors. It seems that at least two major mech-
anisms, non-antigen specific and antigen specific, regulate the 
immune response to environmental allergens in humans. While 
many of environmental components have been studied for years, 
only recently significant progress has been made in identifying 
the genes responsible for susceptibility or expression of atopic 
diseases. Genome-wide screens in various populations have 
identified the locations of susceptibility genes for asthma and 
atopy as well as associated phenotypes such as bronchial hy-
perresponsiveness and increased total IgE concentrations typi-
cal for patients suffering from atopic dermatitis. Further research 
on genetic and environmental relationships is necessary for bet-
ter understanding of atopic processes and development of new 
therapeutic approaches.
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INTRODUCTION
 Immunoglobulin E (IgE) is produced by all in-
dividuals as a defense against large quantities 
of antigens, e.g., during helminthic infestation. 
In contrast, IgE production against common anti-
gens, such as house dust mite, is characteristic for 
atopy. Thus, atopy can be defined as an increased 
tendency to react to environmental agents by pro-
duction of IgE antibodies. Atopic status can be 
manifested clinically as one or more of atopic dis-
orders, which include atopic asthma, atopic der-
matitis, allergic rhinitis and conjunctivitis. Atopic 
disorders form a group of different clinical pheno-
types and therefore a complex pattern of inheri-
tance is strongly suggested (1,2).
 Atopic dermatitis (AD) is a chronic, inflamma-
tory disease that usually starts in early infancy. It is 
characterized by eczematous, inflammatory skin le-
sions and severe xerosis. The prevalence of  AD is 
approximately 20% in the general population, with 
an increasing tendency, especially in developed 
countries (3). According to Hanifin and Rajka, the 
major diagnostic features of AD include personal 
or family history of atopic disease, while among 
minor features there are also elevated serum total 
(tIgE) and antigen specific IgE (asIgE) concentra-
tions (4). Approximately 80% of AD patients pres-
ent high tIgE serum concentration that may cor-
relate with the disease severity. However, in ap-
proximately 10%-20% of AD patients tIgE serum 
concentration stays within the normal range and 
no asIgE are detected (5). Usually first atopic skin 
lesions appear in early infancy and in 45%-50% of 
patients fade during the second year of life. In an-
other 50%-65%, skin lesions persist or relapse after 
puberty. In about 40%-45% of cases, other atopic 
diseases may occur, especially atopic asthma (6). 
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 PATHOGENESIS OF ATOPY
 Immune dysfunction, particularly enhanced 
T-cell activation, plays a pivotal role in atopic 
processes. Exposure to various environmental 
allergens in an atopic individual results in asIgE 
production by B cells. IgE antibodies are pro-
duced after presentation of an antigen fragment 
by antigen presenting cells (APC) and in close 
cooperation with T helper type 2 cells (Th2). IgE 
molecules are bound on the surface of mast cells 
and basophils via high-affinity receptors for Fc 
fragment of immunoglobulins type I (FcεRI). When 
IgE recognizes the allergen, a cascade of immune 
reactions begins. Mast cells and basophils re-
lease inflammatory mediators, such as cytokines. 
These cytokines influence the inflammatory reac-
tion, IgE production (IL-13 and IL-4) and activate 
other inflammatory cells in terms of allergy reac-
tion (IL-5, IL-8, IL-9). Th cells play a critical role in 
the regulation of IgE production. In an acute stage 
of inflammation in AD there is a predominance of 
Th2 cells, whereas in case of chronic skin lesions 
Th1 cells tend to predominate. It is well known that 
specific, complex cytokine pattern of the microen-
vironment determines this biphasic characteristics 
of inflammation in AD patients. It is also stressed 
that certain chemokines (chemotactic cytokines) 
may localize and enhance skin inflammation by 
inducing chemotaxis and activation of inflamma-
tory cell types as well as sustaining Th2 response 
during the Th1-dominant phase of AD (7,8).
GENETIC BACKGROUND OF ATOPY
 Because of the possible effects of many shared 
environmental factors, familial aggregation alone 
is not sufficient to verify the genetic basis of atopic 
diseases. Therefore, twin and family studies are 
required. 
 Twin studies compare disease concordance 
rates between monozygotic and dizygotic twins. 
The degree of reduction from 100% concordance 
in monozygotic twins reflects the degree to which 
environmental factors contribute to the disease. 
Twin studies support the role of genetics in atopic 
disorders but also indicate a possible role of envi-
ronmental factors (9,10).
 There are two main directions of studies on 
genes influencing atopy: searching for those genes 
responsible for increased total IgE levels and for a 
correlation between major histocompatibility com-
plex (MHC) genes and specific IgE response to 
environmental allergens. The overall regulation of 
IgE is genetically determined. The genetic regula-
tion of serum IgE was studied by Marsh et al. in the 
Pennsylvania Old Order Amish, a religious isolated 
group (11). The evidence for linkage with total IgE 
was found within the 5q31.1 region. Further stud-
ies have suggested that the gene coding IL-4 and 
nearby genes in the 5q31.1 regulate production of 
nonspecific IgE. Studies in families with asthma 
have revealed that a polymorphism in the IL-4 pro-
moter is associated with elevated total serum IgE 
levels. An analysis of IL-4 gene expression iden-
tified a higher expression in individuals having T 
(thymine) variant at position 590 that those with C 
(cytosine) polymorphism. Another potential “atopy 
gene” is located in region 11q13 of chromosome 
11. This region contains FCERIB gene of β chain 
high-affinity IgE receptor, which takes part in sig-
nal transduction and activation of mast cells and 
basophils. Polymorphism in positions 181 and 183 
and the presence of leucine correlate with atopy 
(12). Chromosomal region 12q14.3-q24.1, similar 
to chromosome 5q, is rich in candidate genes for 
atopy. This region contains genes for IFN-γ, which 
inhibits IL-4 and a gene for STAT6 protein, which 
is a transcription factor, transducing signal for Th2 
cells differentiation (13). Region 16q21 is also 
a marker of atopy with a gene for IL-4 receptor. 
Mutation in position 1920 of subunit α IL-4R gene 
was observed in 70% of atopic individuals (14). 
Candidate genes Chromosomal regions Function References
IL4, IL13, IL5 5q31.1-q33 B-cell switching to IgE, Th2 response [10,11]
β FcεRI 11q13 Transduction signaling on basophils, mast cells and dendritic cells [12]
IFN-γ, STAT6 12q14.3-q24.1 Inhibits IL-4 activity, transcription factor [13]
α IL-4R 16p21 IgE overproduction [14]
Table 1. Candidate genes and their chromosomal regions showing linkage to total IgE and atopy
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 The HLA-D region in chromosome 6p21.3 con-
tains a group of candidate genes involved in an-
tigen presentation. APC may present antigen to T 
cells which binds it via T-cell receptor (TCR) only 
in the presence of MHC class II molecule on the 
surface of APC (MHC class II restriction). Specific 
responsiveness to ragweed (Ambrosia artemisifo-
lia) allergens Amb a 5 (5 kDa) and Amb a 6 (9.9 
kDa) was studied. The study showed a relation-
ship between the presence of HLA Dw2 molecule 
with specific IgE and IgG antibody responsive-
ness to Amb a 5 allergen but not to larger Amb a 
6 antigen, which is found in higher concentrations. 
Futhermore, HLA-DRβ residues were defined as 
being critical for the immune recognition of the 
major Amb 5 epitope (15,16). 
 Over several years, numerous studies have 
confirmed these findings and associations with 
HLA-DR have been extended to several allergens, 
e.g., house dust mite Der p 1, Der p 2 (17,18). 
Tables 1 and 2 present candidate genes and their 
chromosomal regions, showing linkage to tIgE or 
asIgE and atopy.
 
 GENETICS OF ATOPIC DERMATITIS
 Twin studies of AD performed in 1989 by Lars-
en et al. revealed a coexistence in 72%-86% of 
monozygotic twins and in 21%-23% of dizygotic 
twin pairs, indicating a strong genetic background 
(19). Two genome screens for AD were under-
taken in children. The first one was performed in 
2000 by Lee et al. in families of German and Scan-
dinavian children, and showed linkage to chromo-
some region 3q21 (20). The second screen of Brit-
ish families, performed in 2001 by Cookson et al., 
including children affected by AD, extended Lee’s 
research and revealed another three chromosom-
al regions of linkage to AD on chromosomes 1q21, 
17q25 and 20p (21). The third genome screen car-
ried out by Bardley et al. in Swedish adults with AD 
showed evidence for linkage of AD to chromosome 
region 3p24-22. The latter authors also found sug-
gestive linkage to region 18q21, especially in AD, 
combined with raised allergen-specific IgE levels, 
and a connection between the severity of AD and 
regions 3q14, 13q14, 15q15-14, 17q21 (22). Inter-
esting is the fact that the regions identified in the 
disorder characterized by trichorrhexis invaginata, 
congenital ichthiotic erythrodermia, and atopic di-
athesis. The Netherton’s gene has been localized 
to chromosome 5q31 near the interleukin-4 cyto-
kine cluster and has been identified as SPINK5. 
SPINK5 gene encodes a 15-domain serine prote-
ase inhibitor LEKTI (lympho-epithelial Kazal-type-
related inhibitor), which is expressed in the thy-
mus. Recently, coding polymorphism in SPINK5 
gene (a variant with lysine instead of glutamine 
at position 420) has been reported to be associ-
ated with atopy, asthma and AD. The gene is ex-
pressed in the outer layers of the skin and may 
play a protective role against allergens which are 
serine proteinases (31). Animal models are often 
helpful in identifying genes involved in disease. 
The NC mouse model spontaneously develops 
AD-like skin lesions and elevation of total IgE se-
rum levels. A genetic study of this model revealed 
linkage to chromosome 9, which is homologous to 
human chromosome 11q23 (32). Another mouse 
model of AD is NOA mouse (The Naruto Research 
Institute Otsuka Atrichia). Here linkage has been 
Candidate genes Chromosomal regions Function Reference
HLA-DR 6p21.3 Antigen presentation [15]
TCR 14q11.2-13 Interacts with MHC complex [16]
Table 2. Candidate genes and their chromosomal regions showing linkage to specific IgE and atopy
British 1q21, 17p25, 20p and the German 3q21 
investigations closely correspond with the genes 
known to be psoriasis susceptibility genes (23). 
Genetic region 3q21 is also concerned with a pre-
disposition to asthma, type 1 diabetes, and rheu-
matoid arthritis (24). 
 Candidate genes have also been studied for 
a role in AD. Polymorphism in the β chain of the 
high-affinity receptor for immunoglobulin E (FcεRI-
β) has been screened in different studies on asth-
ma, bronchial hyperresponsiveness, and severe 
atopic dermatitis (25-27). In the same way, a con-
nection between polymorphism of mast cell trypt-
ase (chymase) and AD was revealed in a Japa-
nese population (28). However, these results have 
not been replicated in other studies (29). Allergic 
inflammation is characterized by overexpression 
of family C-C chemokines. A functional mutation 
in the promoter of the RANTES (regulated on ac-
tivation, normal T cell expressed and secreted) 
gene has been identified and is associated with 
AD in children but not with asthma (30). Nether-
ton’s disease is a rare, autosomal recessive skin 
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established in region on chromosomes 13 and 14, 
which are homologous to human locus on 13q14 
and 5q31, respectively (33). 
 Many genome screens have been carried out 
for asthma. Regions of linkage to atopy have been 
identified on chromosomes 5q35, 11q13, 12q, 14q, 
16q and 6p (see Tables 1 and 2). What seems in-
teresting is that regions thought to be linked to 
AD did not totally correspond to those loci. This is 
suggestive of a presence of separate or additional 
genes that may act through atopic mechanisms 
(23).
 Numerous studies are carried out in many 
world centers and methods of molecular genetic 
mapping of genes are becoming ever better. Nev-
ertheless, the “atopy gene” has not yet been iden-
tified. Until now, only some of the genes responsi-
ble for separate parts of the allergic reaction chain 
have been determined. As far as the genetic back-
ground of any disease is concerned, the influence 
of environmental factors is a sine qua non condi-
tion, which, however, is a very difficult task.
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Nivea cream is the only cream containing eucerite. 
From the Nivea collection of Zlatko Puntijar (1933)
